SCHEMBL3533554

SCHEMBL3533554

CCCN(CCC)CC(O)CC

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
RAB9A P51151 1/20 0.40
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
KDM4E B2RXH2 2/20 0.36
MAPK1 P28482 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CA12 O43570 1/20 0.32
CA2 P00918 1/20 0.32
CA9 Q16790 1/20 0.32
HSF1 Q00613 1/20 0.32
TSHR P16473 1/20 0.32
CYP51A1 Q16850 1/20 0.31
ACHE P22303 1/20 0.30
GAA P10253 1/20 0.30
MAPT P10636 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
FDPS P14324 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20063317 0.95 ALDH1A1 (0.37) ALDH1A1RAB9AMEN1KMT2AKDM4E
SCHEMBL5430728 0.89 ALDH1A1 (0.42) ALDH1A1RAB9AMEN1KMT2AKDM4E
SCHEMBL11194743 0.86 KDM4E (0.33) ALDH1A1RAB9AMEN1KMT2AKDM4E
SCHEMBL14136244 0.86 TSHR (0.38) ALDH1A1RAB9AMEN1KMT2AKDM4E
SCHEMBL474323 0.85 KDM4E (0.49) ALDH1A1MEN1KMT2AKDM4EMAPK1
SCHEMBL2881639 0.83 TSHR (0.35) KDM4EMAPK1TDP1TSHR
Bromide SCHEMBL30307038 0.83 KDM4E (0.47) ALDH1A1MEN1KMT2AKDM4EMAPK1
SCHEMBL11699013 0.83 KDM4E (0.44) MEN1KMT2AKDM4EMAPK1TDP1
SCHEMBL81188 0.83 TSHR (0.39) TSHRACHE
SCHEMBL6383273 0.82 KDM4E (0.39) MEN1KMT2AKDM4EMAPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1812401-B1 METHOD FOR PRODUCING PERYLENE-3,4-DICARBOXYLIC ACID IMIDES BASF SE (DE) 2015-06-24 EP disclosed
US-7799920-B2 Method for producing perylene-3,4-dicarboxylic acid imides BASF AKTIENGESELLSCHAFT (DE) 2010-09-21 US disclosed
US-20080114170-A1 Method For Producing Perylene-3,4-Dicarboxylic Acid Imides BASF AKTIENGESELLSCHAFT (DE) 2008-05-15 US disclosed
EP-1812401-A1 METHOD FOR PRODUCING PERYLENE-3,4-DICARBOXYLIC ACID IMIDES BASF AKTIENGESELLSCHAFT (DE) 2007-08-01 EP disclosed
WO-2006050860-A1 METHOD FOR PRODUCING PERYLENE-3,4-DICARBOXYLIC ACID IMIDES BASF AKTIENGESELLSCHAFT (DE) 2006-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080114170-A1 Method For Producing Perylene-3,4-Dicarboxylic Acid Imides CPNE4, IDH3A, RPL23A ALDH1A1 1966/4885RAB9A 428/4885MEN1 473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.